Bioinformatics prediction and experimental verification identify a cuproptosis-related gene signature as prognosis biomarkers of hepatocellular carcinoma

被引:0
|
作者
Wang, Weiwei [1 ]
He, Zhiguo [1 ]
Jia, Haowen [2 ]
Zhang, Jiansheng [1 ]
Qi, Feng [3 ]
机构
[1] Tianjin Med Univ, Baodi Clin Coll, Dept Gen Surg, 8 Guangchuan Rd, Tianjin 301800, Peoples R China
[2] Tianjin Med Univ Gen Hosp, Airport Hosp, Dept Gen Surg, Tianjin, Peoples R China
[3] Tianjin Med Univ Gen Hosp, Dept Gen Surg, 154 Anshan Rd, Tianjin 300052, Peoples R China
基金
中国国家自然科学基金;
关键词
Cuproptosi; gene signature; hepatocellular carcinoma (HCC); prognostic analysis; immune infiltration; PYRUVATE-DEHYDROGENASE COMPLEX; CELL-DEATH; COPPER DEFICIENCY; OXIDATIVE STRESS; CANCER; DISULFIRAM; INHIBITION; DRUG; MITOCHONDRIA; EXPRESSION;
D O I
10.21037/tcr-23-1561
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Hepatocellular carcinoma (HCC) of which its prognostic prediction is still unclarified is a highly heterogeneous disease. Cuproptosis is a form of cell death that depends on copper regulation. Whether the cuproptosis-related genes can be the prognostic indicators of HCC is yet to be elucidated. The aim of this study is to investigate whether cuproptosis-related genes play a role in HCC and can be used as a diagnostic index to predict the occurrence of liver cancer. Methods: We downloaded HCC patients' gene expression profiles and their corresponding clinical data from a public database. To screen data, we used single factor Cox regression analysis, meanwhile, polymerase chain reaction (PCR) was used for the verification. After that, the risk score was calculated and the relationship between risk score and clinical factors was analyzed. Besides, a nomogram map was constructed for predicting the prognosis of HCC, and calibration map and decision curve analysis (DCA) map were used to test the model. Results: Compared to the high expression group of four cuproptosis-related genes, the low expression group showed better overall survival (OS) [hazard ratio (HR) =2.58; 95% confidence interval (CI): 1.72-3.89, P<0.001]. The expression of the four cuproptosis-relate genes increased in liver cancer cell lines compared to liver cell lines (P<0.05). Based on these four genes, we calculated the risk score and divided them into two groups as high-risk group and low-risk group. The risk factor map showed the high-risk group had shorter survival time and the four genes were highly expressed. The area under curve (AUC) of receiver operating characteristic (ROC) prediction curve for the first year was 0.726. Risk scores were closely related to clinical factors and immune cells. Finally, we constructed a nomogram for predicting the prognosis of HCC. Conclusions: The risk score for cuproptosis-related genes was established and involved in the construction of the nomogram, providing a new perspective on the prognosis and copper metabolism of HCC.
引用
收藏
页码:2985 / 3002
页数:18
相关论文
共 50 条
  • [21] A novel cuproptosis-related gene signature to predict prognosis in Glioma
    Mengyang Zhang
    Xiaobai Liu
    Di Wang
    Xuelei Ruan
    Ping Wang
    Libo Liu
    Yixue Xue
    BMC Cancer, 23
  • [22] A Novel Cuproptosis-Related Gene Signature Predicts Prognosis in Papillary Thyroid Carcinoma Patients
    Cao, Jun
    Zhang, Shijia
    Zhou, Kehui
    Mao, Xiaochun
    Zhao, Ming
    Shang, Jinbiao
    Lan, Xiabin
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024,
  • [23] The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis
    Zhao, Xueying
    Chen, Jin
    Yin, Shangqi
    Shi, Jingren
    Zheng, Mei
    He, Chaonan
    Meng, Huan
    Han, Ying
    Han, Jinyu
    Guo, Jingjing
    Yuan, Zhengrong
    Wang, Yajie
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [24] A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma
    Li, Yaoting
    Zeng, Xuezhen
    FRONTIERS IN PHARMACOLOGY, 2023, 13
  • [25] Construction and validation of a cuproptosis-related lncRNA prognosis signature in bladder carcinoma
    Song, Jinbo
    Sun, Xiaoke
    Wang, Ting
    Yan, Li
    Su, Pengxiao
    Yuan, Leihong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (13) : 11207 - 11221
  • [26] A novel cuproptosis-related prognostic gene signature in adrenocortical carcinoma
    Gao, Wenjun
    He, Xiaoyan
    Huangfu, Qi
    Xie, Yanqi
    Chen, Keliang
    Sun, Chengfang
    Wei, Jingchao
    Wang, Bohan
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (21-22)
  • [27] Construction and validation of a cuproptosis-related lncRNA prognosis signature in bladder carcinoma
    Jinbo Song
    Xiaoke Sun
    Ting Wang
    Li Yan
    Pengxiao Su
    Leihong Yuan
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 11207 - 11221
  • [28] Construction of a Cuproptosis-Related Gene Signature for Predicting Prognosis in Gastric Cancer
    Yongli Hu
    Yan Du
    Zhisheng Qiu
    Pengwei Bai
    Zhaozhao Bai
    Chenglou Zhu
    Junhong Wang
    Tong Liang
    Mingxu Da
    Biochemical Genetics, 2024, 62 : 40 - 58
  • [29] Construction of a Cuproptosis-Related Gene Signature for Predicting Prognosis in Gastric Cancer
    Hu, Yongli
    Du, Yan
    Qiu, Zhisheng
    Bai, Pengwei
    Bai, Zhaozhao
    Zhu, Chenglou
    Wang, Junhong
    Liang, Tong
    Da, Mingxu
    BIOCHEMICAL GENETICS, 2024, 62 (01) : 40 - 58
  • [30] Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma
    Shi, Yuanxin
    Qiu, Peng
    Zhao, Kai
    Li, Xiangyu
    Feng, Yunxiang
    Deng, Zhengdong
    Wang, Jianming
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10